Pipeline

• Product 1: A molecular diagnostic test to identify patients who will respond to activated Protein C (Xigris, the only FDA approved drug for sepsis).
• Drug Re-profile: Sirius' technology can be applied towards previously failed drugs, drugs in clinical trials and new indications for currently approved drugs.